Smiths Falls-based Canopy Growth will study the effects on cannabinoids on patients facing complications from concussions thanks to a new partnership with the NHL Alumni Association and Neeka Health Canada.
If successful, the partners hope the research could unlock new avenues to use cannabinoids in post-concussion treatment for athletes and everyday patients.
The local pot producer announced over the weekend it will work with its partners to determine how effective cannabis can be in addressing common post-concussion complications, such as depression, dementia or chronic traumatic encephalopathy (CTE).
OBJ360 (Sponsored)
Touchdowns & Team Building: Why Ottawa’s Top Companies Are Hosting Events with the REDBLACKS
With a renewed roster and sold-out premium spaces in back-to-back seasons, the REDBLACKS are doubling down on game day experiences that aren’t just for die-hard fans, they’re for forward-thinking businesses
Nicole Arranz lights up whenever she sees or hears children visiting Perley Health’s east-end Ottawa campus. “My mom loves kids, and being around kids brings life to her,” said Josée
The research will look to improve cognitive functions for the estimated 1.6 million to 3.8 million athletes that suffer concussions annually, 10 to 15 per cent of whom go on to develop symptoms of mental degradation. About 100 former NHL players will participate in the study.
Trials will begin this summer and are expected to last one year.
